ARCHIVES

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

Cancer Center Directors Contemplate the Role of Centers In the 21st Century

May 7, 1999

Alimta Granted Approval As NSCLC Continuation Therapy

November 25, 2011

Final Issue of ‘78

December 15, 1978

NSABP’s Pink Sheet; Fisher’s Control Had A Downside, Review Said

June 24, 1994

No difference between digital or film mammograms, study finds.

September 23, 2005

ACS Survey Finds Need for Cancer Education Among Hispanic Americans

August 2, 1985